We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon.
- Authors
Ikeda, Masafumi; Fujiyama, Shigetoshi; Tanaka, Motohiko; Sata, Michio; Ide, Tatsuya; Yatsuhashi, Hiroshi; Watanabe, Hiroshi
- Abstract
Interferon (IFN) is expected to prevent the progression of hepatitis C virus infection to cirrhosis and the development of hepatocellular carcinoma (HCC), but there have been several reports of the development of HCC after a sustained response to IFN. Our aim was to elucidate the incidence and clinical features of, and risk factors for, HCC in sustained responders to IFN, taken for the treatment of chronic hepatitis C.
- Publication
Journal of gastroenterology, 2005, Vol 40, Issue 2, p148
- ISSN
0944-1174
- Publication type
Journal Article
- DOI
10.1007/s00535-004-1519-2